Immunwork, Inc.: Clinical Trials

3 trials sponsored by Immunwork, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Not yet recruiting 1

Follow Immunwork, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Safety and Efficacy of TE-8105 in Overweight or Obesity Participants
TE-8105 MAD Cohort 1, TE-8105 MAD Cohort 2, TE-8105 MAD Cohort 3 - Overweight and Obesity
Phase 2Not yet recruitingImmunwork, Inc.2042026-10-012026-10-05
A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes
TE-8105 SAD Cohort 1, TE-8105 SAD Cohort 3, TE-8105 SAD Cohort 5 (Adaptive cohort) - Overweight and Obesity
Phase 1 / Phase 2CompletedImmunwork, Inc.382024-07-092026-01-09
A Phase 1 Study of TE-8214 Solution in Healthy Volunteers
TE-8214 - SAD, Placebo - Acromegaly
Phase 1CompletedImmunwork, Inc.322024-06-182025-05-20

Conditions studied

Obesity (2)  ·  Overweight (2)  ·  Acromegaly (1)

Countries

Australia (3)

Results publications

PMID 42712757